InvestSMART

Chrysos Corporation Limited (ASX: C79) - Announcements

- Current share price for C79 : $7.780

ASX company news and announcements for Chrysos Corporation Limited (C79) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Chrysos Corporation Limited (C79) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Chrysos Corporation Limited (C79), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Chrysos Corporation Limited (C79)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$906 Notice of FY25 Results 29 Jul 2025 8:22AM $5.160 $7.780 risen by 50.78%
$906 Notification of cessation of securities - C79 28 Jul 2025 2:01PM $5.205 $7.780 risen by 49.47%
$906 Notification of cessation of securities - C79 25 Jul 2025 9:44AM $5.100 $7.780 risen by 52.55%
$906 Appendix 3Y - Dirk Treasure 25 Jul 2025 9:43AM $5.100 $7.780 risen by 52.55%
$906 Appendix 3Y - Robert Adamson 20 Jun 2025 4:18PM $4.900 $7.780 risen by 58.78%
$906 Appendix 3Y - Dirk Treasure 20 Jun 2025 4:13PM $4.900 $7.780 risen by 58.78%
$906 Application for quotation of securities - C79 20 Jun 2025 4:10PM $4.900 $7.780 risen by 58.78%
$906 Application for quotation of securities - C79 27 May 2025 11:22AM $4.595 $7.780 risen by 69.31%
$906 Chrysos Enters MSA With Newmont Corporation 9 May 2025 9:56AM $4.130 $7.780 risen by 88.38%
$906 Macquarie Australia Conference Presentation 6 May 2025 8:38AM $3.940 $7.780 risen by 97.46%
$906 May 2025 Trading Update 5 May 2025 8:52AM $4.140 $7.780 risen by 87.92%
$906 Shaw and Partners 2025 TechRise Conference Presentation 5 May 2025 8:48AM $4.140 $7.780 risen by 87.92%
$906 Cessation of Quarterly Reporting Obligations 2 Apr 2025 9:24AM $4.120 $7.780 risen by 88.83%
$906 Application for quotation of securities - C79 1 Apr 2025 9:18AM $4.120 $7.780 risen by 88.83%
$906 Appendix 3Y - Robert Adamson 31 Mar 2025 5:09PM $4.120 $7.780 risen by 88.83%
$906 Application for quotation of securities - C79 31 Mar 2025 4:28PM $4.120 $7.780 risen by 88.83%
$906 Appendix 3Y - Eric Ford 19 Mar 2025 8:16AM $4.340 $7.780 risen by 79.26%
$906 Application for quotation of securities - C79 17 Mar 2025 12:24PM $4.530 $7.780 risen by 71.74%
$906 Chrysos Corporation 1H FY25 Results 20 Feb 2025 9:52AM $5.000 $7.780 risen by 55.60%
$906 Interim Financial Report Half Year Ended 31 December 2024 20 Feb 2025 9:52AM $5.000 $7.780 risen by 55.60%
$906 1H FY25 Results Presentation 20 Feb 2025 9:50AM $5.000 $7.780 risen by 55.60%
$906 Appendix 4D HY25 20 Feb 2025 9:49AM $5.000 $7.780 risen by 55.60%
$906 CFO and Company Secretary Personal Legal Matter 13 Feb 2025 9:52AM $5.110 $7.780 risen by 52.25%
$906 Notification of cessation of securities - C79 12 Feb 2025 2:30PM $5.100 $7.780 risen by 52.55%
$906 Notice of 1H25 Result 6 Feb 2025 8:43AM $5.190 $7.780 risen by 49.90%

76 - 100 of 337 results

Page 4 of 14

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.